Data from Pharmawand - Curated by Marshall Pearce - Date added 12 January 2018
Spectra WaveWriter Spinal Cord Stimulator (SCS) System is FDA approved to treat chronic pain. SCS is the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception therapy. The system allows physicians and patients to combine therapeutic options, customize therapy and capture real-time feedback designed to treat chronic and debilitating pain successfully.
Spinal Cord Stimulation (SCS) System is an implanted spinal cord stimulation system that was previously indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including one-sided (unilateral) or two-sided (bilateral) pain associated with the following: failed back surgery syndrome, intractable low back and leg pain. The expanded indications include unilateral and bilateral pain associated with Complex Regional Pain Syndrome (CRPS) Type I and II. Additional associated conditions may be: radicular pain syndrome, radiculopathies resulting in pain secondary to failed back surgery syndrome or herniated disc, epidural fibrosis, degenerative disc disease, arachnoiditis, and multiple back surgeries.
The two main components include: 1. a stimulator device (signal generator) implanted under the skin that sends electrical signals to the spinal cord through an insulated lead wire, and 2. a hand-held remote control that allows the patient to control the implanted stimulator device in order to achieve the best pain control.